However, in the PLA2R- group and the PLA2R+ group, there was no significant difference in the remission rate between the FSGS+ group and the FSGS- group, between the PLA2R+ group and the FSGS- group, or between the FSGS+ group and the FSGS- group. The gene discussed is PLA2R1; the disease is focal segmental glomerulosclerosis.